Wednesday, September 28, 2016

Biotonus




Biotonus may be available in the countries listed below.


Ingredient matches for Biotonus



Mosapride

Mosapride is reported as an ingredient of Biotonus in the following countries:


  • Peru

International Drug Name Search

Posted by at No comments:
Labels:

Riomet


Riomet is a brand name of metformin, approved by the FDA in the following formulation(s):


RIOMET (metformin hydrochloride - solution; oral)



  • Manufacturer: RANBAXY

    Approval date: September 11, 2003

    Strength(s): 500MG/5ML [RLD]

Has a generic version of Riomet been approved?


No. There is currently no therapeutically equivalent version of Riomet available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Riomet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Liquid formulation of metformin
    Patent 6,890,957
    Issued: May 10, 2005
    Inventor(s): Chandran; Ravi & Gogia; Ashish
    Assignee(s): Ranbaxy Laboratories Limited
    The present invention is directed to a liquid formulation of metformin or its pharmaceutically acceptable salts thereof. The liquid pharmaceutical composition comprises a therapeutically effective amount of metformin or its pharmaceutically acceptable salt, in a liquid carrier, which may also include a sweetener that does not increase the blood glucose level of a subject after ingestion thereof. In one embodiment, it may also include alkyl hydroxyethylcellulose, and/or a polyhydroxy alcohol. In another embodiment, the carrier may contain a sweetener, mineral acid, and bicarbonate salt maintained at a pH of 4.0 to 9.0. It is useful for treating hyperglycemia and diabetes.
    Patent expiration dates:

    • September 14, 2023
      ✓ 
      Drug product



See also...

  • Riomet Consumer Information (Drugs.com)
  • Riomet Solution Consumer Information (Wolters Kluwer)
  • Riomet Consumer Information (Cerner Multum)
  • Riomet Advanced Consumer Information (Micromedex)
  • Metformin Consumer Information (Drugs.com)
  • Metformin Consumer Information (Wolters Kluwer)
  • Metformin Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Metformin Solution Consumer Information (Wolters Kluwer)
  • Metformin Consumer Information (Cerner Multum)
  • Metformin Advanced Consumer Information (Micromedex)
  • Metformin Hydrochloride AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Raciper-D




Raciper-D may be available in the countries listed below.


Ingredient matches for Raciper-D



Domperidone

Domperidone is reported as an ingredient of Raciper-D in the following countries:


  • India

Esomeprazole

Esomeprazole magnesium, trihydrate (a derivative of Esomeprazole) is reported as an ingredient of Raciper-D in the following countries:


  • India

International Drug Name Search

Posted by at No comments:
Labels:

Suprenza


Suprenza is a brand name of phentermine, approved by the FDA in the following formulation(s):


SUPRENZA (phentermine hydrochloride - tablet, orally disintegrating; oral)



  • Manufacturer: CITIUS PHARMS

    Approval date: June 13, 2011

    Strength(s): 15MG, 30MG [RLD]

Has a generic version of Suprenza been approved?


No. There is currently no therapeutically equivalent version of Suprenza available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Suprenza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
    Patent 6,149,938
    Issued: November 21, 2000
    Inventor(s): Bonadeo; Daniele & Ciccarello; Franco & Pagano; Aberto
    Assignee(s): Elan Pharma International Limited
    A process for making a granulate composition suitable to the preparation of an oral solid form that can disintegrate rapidly inside the buccal cavity is provided as well as the granulate compositions and obtained.
    Patent expiration dates:

    • July 23, 2018
      ✓ 
      Drug product



See also...

  • Phentermine Consumer Information (Drugs.com)
  • Phentermine Consumer Information (Wolters Kluwer)
  • Phentermine Resin Consumer Information (Wolters Kluwer)
  • Phentermine Consumer Information (Cerner Multum)
  • Phentermine AHFS DI Monographs (ASHP)
  • Phentermine Hydrochloride AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Cardene SR


See also: Generic Cardene


Cardene SR is a brand name of nicardipine, approved by the FDA in the following formulation(s):


CARDENE SR (nicardipine hydrochloride - capsule, extended release; oral)



  • Manufacturer: EKR THERAP

    Approval date: February 21, 1992

    Strength(s): 30MG [RLD], 60MG [RLD]

Has a generic version of Cardene SR been approved?


No. There is currently no therapeutically equivalent version of Cardene SR available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cardene SR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cardene SR.

See also...

  • Cardene SR Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Cardene SR Consumer Information (Cerner Multum)
  • Cardene SR Advanced Consumer Information (Micromedex)
  • Nicardipine Consumer Information (Wolters Kluwer)
  • Nicardipine Capsules Consumer Information (Wolters Kluwer)
  • Nicardipine Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Nicardipine Consumer Information (Cerner Multum)
  • Nicardipine Advanced Consumer Information (Micromedex)
  • Nicardipine Intravenous Advanced Consumer Information (Micromedex)
  • Nicardipine AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Requip


See also: Generic Requip XL


Requip is a brand name of ropinirole, approved by the FDA in the following formulation(s):


REQUIP (ropinirole hydrochloride - tablet; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: September 19, 1997

    Strength(s): EQ 0.25MG BASE [RLD][AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: GLAXOSMITHKLINE

    Approval date: January 27, 1999

    Strength(s): EQ 3MG BASE [AB], EQ 4MG BASE [AB]

Has a generic version of Requip been approved?


Yes. The following products are equivalent to Requip:


ropinirole hydrochloride tablet; oral



  • Manufacturer: ALEMBIC LTD

    Approval date: March 24, 2010

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: APOTEX

    Approval date: February 7, 2012

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: COREPHARMA

    Approval date: May 20, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: February 25, 2010

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: PRINSTON INC

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: PRINSTON INC

    Approval date: July 11, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: ROXANE

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: ROXANE

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: May 5, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB]


  • Manufacturer: TEVA

    Approval date: May 19, 2008

    Strength(s): EQ 5MG BASE [AB]


  • Manufacturer: WOCKHARDT

    Approval date: May 29, 2008

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: June 1, 2009

    Strength(s): EQ 0.25MG BASE [AB], EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 2MG BASE [AB], EQ 3MG BASE [AB], EQ 4MG BASE [AB], EQ 5MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Requip. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Requip.

See also...

  • Requip Consumer Information (Drugs.com)
  • Requip Consumer Information (Wolters Kluwer)
  • Requip Consumer Information (Cerner Multum)
  • Requip Advanced Consumer Information (Micromedex)
  • Requip AHFS DI Monographs (ASHP)
  • Ropinirole Consumer Information (Wolters Kluwer)
  • Ropinirole Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Ropinirole Consumer Information (Cerner Multum)
  • Ropinirole Advanced Consumer Information (Micromedex)
  • Ropinirole Hydrochloride AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Restavit




Restavit may be available in the countries listed below.


Ingredient matches for Restavit



Doxylamine

Doxylamine succinate (a derivative of Doxylamine) is reported as an ingredient of Restavit in the following countries:


  • Australia

International Drug Name Search

Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)